Revaia deepens commitment to Hublo
Revaia, a European growth-stage investment firm, has closed a €40 million reinvestment vehicle dedicated to Hublo, reinforcing its backing of the healthcare workforce management platform following the company’s 2025 exit, according to details shared in a recent announcement.
The reinvestment structure signals continued conviction in Hublo’s growth trajectory and the broader demand for digital tools that help hospitals, clinics, and care homes manage staffing shortages and administrative burdens—pressures that have remained acute across Europe in the years since the pandemic.
Why healthcare staffing software remains a priority
Healthcare providers across Europe continue to face persistent workforce constraints, complex compliance requirements, and operational inefficiencies driven by fragmented or outdated scheduling and HR processes. During the pandemic, hospitals and clinics were forced to adopt more flexible and responsive staffing practices, accelerating interest in software that can centralise workforce planning and internal communication.
Hublo positions itself as a sector-specific platform designed to address these realities. The company’s software supports workforce planning functions including recruitment, shift scheduling, internal mobility, and communication—areas where delays or manual processes can translate directly into care disruptions and staff burnout.
Hublo’s origins and leadership
Hublo was founded in 2020 following the merger of two French startups, Whoog and MedGo. The combined company is led by co-founders Adrien Beata and Antoine Loron, who built their earlier ventures around the same core problem: helping healthcare organisations fill shifts reliably while reducing administrative overhead for already overstretched teams.
By consolidating the capabilities of the two companies into one platform, Hublo aimed to offer an end-to-end toolset for healthcare workforce and talent management rather than a point solution for a single workflow.
How Hublo differentiates from generalist workforce tools
While workforce management is a crowded market, Hublo emphasises its exclusive focus on healthcare. The company contrasts its approach with multi-industry providers such as Quinyx, Deputy, and UKG (formerly Kronos), arguing that healthcare requires tailored features and integrations that generic HR and scheduling systems often lack.
According to the company, its platform centralises recruitment, planning, communication, and analytics so managers can fill shifts, track staff availability, and maintain compliance. The pitch is particularly relevant for large organisations where staffing decisions involve multiple departments, variable shift patterns, and strict rules around qualifications and working hours.
Key terms highlighted in the company’s positioning include “real-time staffing insights,” “seamless integration with hospital IT systems,” and “analytics,” reflecting the industry’s push toward operational visibility and standardised reporting across facilities.
Scale and reported impact in Europe
By 2025, Hublo reported adoption by 22,000 managers across 5,000 facilities, supporting nearly one million healthcare professionals. The company also claims users save an average of 2.5 hours of administrative time per day—an efficiency gain that, if sustained at scale, could materially reduce back-office workload and improve responsiveness when staffing gaps emerge.
In a sector where workforce costs represent a significant share of operating budgets and overtime can surge during periods of strain, tools that improve scheduling accuracy and internal mobility can have direct financial implications alongside operational benefits.
What the €40M reinvestment vehicle signals
The €40 million reinvestment vehicle from Revaia is designed to extend the investor’s exposure to Hublo after the company’s 2025 exit. Such vehicles are commonly used by growth investors to maintain or increase participation in a high-performing asset, particularly when a company continues to expand post-transaction or prepares for further strategic moves.
For Hublo, the additional backing provides capital and investor support as it enters a new phase focused on product development and geographic scale. For Revaia, it represents a renewed bet on a platform operating in a defensible niche with long-term demand drivers, including ageing populations, clinician shortages, and continued digitisation of hospital operations.
Next steps: technology investment and expansion
Hublo said it plans to invest further in technology and accelerate its European expansion through a mix of organic growth and acquisitions. Expansion via M&A can be particularly relevant in healthcare IT, where local market dynamics, procurement practices, and integration requirements can vary significantly by country.
The company’s stated ambition is to become Europe’s leading platform for healthcare workforce and talent management—positioning its software as infrastructure that helps healthcare organisations deliver care more reliably by ensuring the right staff are available at the right time.
Bottom line
With a €40 million reinvestment vehicle, Revaia is doubling down on Hublo as the healthtech company scales its healthcare-first workforce management platform across Europe. The move underscores sustained investor focus on operational software that addresses staffing shortages and administrative strain in critical public and private healthcare systems.
Related
